Process development of 5-fluoro-3-[3-[4-(5-methoxy-4-pyrimidinyl)-1-piperazinyl]propyl]-1H-indole dihydrochloride

被引：22
|
作者：
Anderson, NG
Ary, TD
Berg, JL
Bernot, PJ
Chan, YY
Chen, CK
Davies, ML
DiMarco, JD
Dennis, RD
Deshpande, RP
Do, HD
Droghini, R
Early, WA
Gougoutas, JZ
Grosso, JA
Harris, JC
Haas, OW
Jass, PA
Kim, DH
Kodersha, GA
Kotnis, AS
LaJeunesse, J
Lust, DA
Madding, GD
Modi, SP
Moniot, JL
Nguyen, A
Palaniswamy, V
Phillipson, DW
Simpson, JH
Thoraval, D
Thurston, DA
Tse, K
Polomski, RE
Wedding, DL
Winter, WJ
机构：
[1] Bristol Myers Squibb, Pharmaceut Res Inst, Dept Chem Proc Dev, New Brunswick, NJ 08903 USA
[2] Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Solid State Chem, Princeton, NJ 08543 USA
[3] Bristol Myers Squibb Co, Chem Proc Res, Quebec City, PQ J5R 1J1, Canada
来源：
ORGANIC PROCESS RESEARCH & DEVELOPMENT | 1997年 / 1卷 / 04期
关键词：
D O I：
10.1021/op970213h
中图分类号：
O69 [应用化学];
学科分类号：
081704 ;
摘要：
5-fluoro-3-[3-[4-(5-methoxy-4-pyrimidinyl)-1-piperazinyl]-propyl]-1H-indole dihydrochloride (1) facilitates 5-HT neurotransmission and was an antidepressant drug candidate. The development of a safe, rugged process for the large-scale, chromatography-free preparation of this compound is described, The main areas of optimization included a Fischer indole synthesis, preparation and chlorination of a monohydroxypyrimidine, and coupling of the resultant fragments to prepare the drug substance.
引用
收藏
页码：300 / 310
页数：11
相关论文
共 50 条
  • [31] STRUCTURE OF 3-(2-[4-(2-METHOXYPHENYL)-1-PIPERAZINYL]ETHYL)-2,4(1H,3H)-QUINAZOLINEDIONE MONOHYDRATE (SGB1534)
    NAWATA, Y
    NAGANO, H
    OCHI, K
    ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 1988, 44 : 183 - 185
  • [32] Voltammetric determination of a novel 1-(3-Fluoro-benzenesulfonyl)-5-{3-[5-(3-methoxy-phenyl)-2-methyl-2H-[1,2,4]triazol-3-yl]-phenyl}-1H-indole using glassy carbon electrode in a Britton-Robinson buffer
    Alghamdi, Ali F.
    MOROCCAN JOURNAL OF CHEMISTRY, 2014, 2 (04): : 392 - 402
  • [33] 2-[2-(5-Ethoxy-4-methoxy-2-nitrophenyl)vinyl]-1H-indole
    Sankaranarayanan, R
    Yogavel, M
    Velmurugan, D
    Srinivasan, PC
    Raj, SSS
    Fun, HK
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2003, 59 : O672 - O674
  • [34] Metabolism of an atypical antipsychotic agent, 3-[4-[4-(6-fluorobenzo[B]thien-3-yl)-1-piperazinyl]butyl]-2,5,5-trimethyl-4-thiazolidinone (HP236)
    Mutlib, AE
    Jurcak, J
    Hrib, N
    DRUG METABOLISM AND DISPOSITION, 1996, 24 (10) : 1139 - 1150
  • [35] STRUCTURE OF 2-(3-[4-(M-CHLOROPHENYL)-1-PIPERAZINYL]PROPYL)-S-TRIAZOLO-[4,3-A]PYRIDIN-3(2H)-ONE HYDROCHLORIDE, TRAZODONE HYDROCHLORIDE
    FILLERS, JP
    HAWKINSON, SW
    ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE, 1979, 35 (FEB): : 498 - 500
  • [36] 3-(4-methoxyphenyl)-1′,6,6-trimethyl-4,5,6,7-tetrahydrospiro[1-benzofuran-2,3′(3H,2′H)-1H-indole]-2′,4-dione
    Gayathri, D.
    Velmurugan, D.
    Ravikumar, K.
    Savitha, G.
    Perumal, P. T.
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2007, 63 : O1034 - O1036
  • [37] Design, Synthesis of 3-(5-Substituted Phenyl-[1,3,4]oxadiazol-2-yl)-1H-indole and Its Microbial Activity
    Suryawanshi, Manohar D.
    Suryawanshi, Ganesh D.
    Mhaske, Pravin C.
    Karpe, Dnyaneshwar G.
    Kamble, Komal R.
    Rode, Sagar J.
    Sudrik, Vilas A.
    Lawande, Shamrao P.
    CHEMISTRY & BIODIVERSITY, 2023, 20 (03)
  • [38] LIQUID-CHROMATOGRAPHIC ANALYSIS OF A NEW ANTIHYPERTENSIVE AGENT, 3-[4-[4-(3-METHYLPHENYL)-1-PIPERAZINYL]BUTYL]-2,4-IMIDAZOLIDINEDIONE, IN PLASMA
    ELDON, MA
    WEBB, CL
    JOURNAL OF CHROMATOGRAPHY, 1986, 383 (01): : 194 - 200
  • [39] 5,5′-dimethoxy-3,3′-(3-fluorophenylmethanediyl)bis(1H-indole)
    Tang, Shi-Gui
    Zhang, Dong-Mei
    Wu, Wen-Yuan
    Shan, Liu
    Guo, Cheng
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2006, 62 : O4691 - O4692
  • [40] 5,5′-dimethoxy-3,3′-(3-nitrophenylmethanediyl)-bis(1H-indole)
    Guo, Cheng
    Zhang, Dong-Mei
    Tang, Qing-Gang
    Sun, Hong-Shun
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2006, 62 : O3994 - O3995
12345